Launch of Thomson Clinical Xpert Delivers Essential Medical Information to Physicians via PDAs

THOMSONThomson, a leading provider of clinical and management decision support solutions to healthcare professionals, announced the launch of Thomson Clinical Xpert™ for PDAs. A powerful new medical reference and decision-support tool, Thomson Clinical Xpert puts authoritative drug, disease and laboratory information instantly into the hands of physicians and other prescribers, nurses, pharmacists, and clinical trainees, helping them to make important decisions at the point of care, and reducing the chances of medical errors.

The launch of this new application, which will help address quality and safety issues such as drug interactions, comes at a time when medical errors and patient safety continue to be a national concern – one underscored by a recent report from the Institute of Medicine that noted medication errors alone still harm 1.5 million patients per year.

Whether in the hospital or a medical office, Thomson Clinical Xpert enhances healthcare professionals' ability to make the right decisions quickly, helping to avoid errors and improve the quality of care. Thomson, known and trusted by healthcare professionals as the company that produces the Physicians' Desk Reference® (PDR), developed Thomson Clinical Xpert to give healthcare professionals fast, convenient access to the evidence-based information they need to support or confirm diagnosis and treatment decisions. This release extends the commitment of Thomson to help improve medication safety wherever it is needed. Future Thomson Clinical Xpert releases will feature desktop and online access to additional workflow tools for medication reconciliation, pharmacy intervention and reporting, coding compliance and executable order sets.

Dr. Jerry Osheroff, chief clinical informatics officer at Thomson and lead author of the American Medical Informatics Association Roadmap for National Action on Clinical Decision Support, said Thomson Clinical Xpert will be a useful tool in efforts to improve the safety and quality of healthcare. "We know that clinicians are committed to eliminating errors and ensuring the most effective care for their patients," he said. "Thomson Clinical Xpert improves point-of-care access to consistent, authoritative medical knowledge for all those who play a direct role in patient care, reducing the risk of medical errors. The ultimate beneficiary is, of course, the patient."

Thomson Clinical Xpert features premium content from Thomson Micromedex, one of the most respected providers of evidence-based clinical information. Experienced physicians, pharmacists, toxicologists, nurses and other healthcare professionals at Micromedex develop and review Thomson Clinical Xpert content, giving clinicians information of unparalleled authority and accuracy, including:

  • A searchable database of more than 4,000 drugs with comprehensive indications, dosage and interactions information
  • Details on more than 400 laboratory tests and their interpretations
  • Toxicology reports on more than 200 of the most common poisons and drug overdoses
  • A comprehensive disease database that offers differential diagnoses, therapeutics and evidence-based recommendation ratings
  • Detailed information about alternative medicines

Thomson Clinical Xpert also features drug interaction tools, convenient medical calculators and "Xpert Alerts"— electronic advisories regarding key drug changes or treatment studies delivered directly to users PDA, desktop or PDR.net account.

Delaware family practitioner John Hale, M.D., said he uses Thomson Clinical Xpert on a daily basis to look up dosages, maximum dosages and drug interactions. "I use my PDA in the exam room without having to leave the room, or the discussion to look up pertinent information," he noted. "I also have used the lab and diagnosis sections while making rounds in the hospital. Having a library like this in my pocket PC is a real time saver."

Osheroff noted that a 2005 study found that more than 87 percent of physicians reported using PDAs, and as many as 50 percent say they frequently refer to PDA-stored clinical information. "As more and more clinicians rely on PDAs, combining the convenience of a PDA with comprehensive, accurate medical information provided by a trusted source such Thomson is going to be an invaluable tool to support clinical practice," he said.

For further information, please visit: www.thomsonclinicalxpert.com

About The Thomson Corporation
The Thomson Corporation (www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...